Caveat against the use of FEIBA in combination with recombinant factor VIIa [7]

Journal of Thoracic and Cardiovascular Surgery

Volumn 126, Issue 5, 2003, Pages 1667-1668

  Von Heymann, Christian ^a   Ziemer, Sabine ^a   Kox, Wolfgang J ^a   Spies, Claudia ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; ANTIFIBRINOLYTIC AGENT; APROTININ; FIBRIN; FIBRINOGEN; FRESH FROZEN PLASMA; HEPARIN; RECOMBINANT BLOOD CLOTTING FACTOR 8; TRANEXAMIC ACID;

BLEEDING; BLOOD CLOTTING; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG SAFETY; DRUG USE; EXTRACORPOREAL OXYGENATION; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; HEART TRANSPLANTATION; HEMOSTASIS; HUMAN; LETTER; PATIENT MONITORING; PRESCRIPTION; PRIORITY JOURNAL; THROMBOSIS;

EID: 0344493891     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(03)01198-X     Document Type: Letter

References (8)

1. Bui JD, Despotis GD, Trulock EP, Patterson GA, Goodnough LT. Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII. J Thorac Cardiovasc Surg. 2002;124:852-4.
2. Gruen DR, Winchester PH, Brill PW, Ramirez E. Magnetic resonance imaging of myocardial infarction during prothrombin complex concentrate therapy of hemophilia A. Pediatr Radiol. 1997;27:271-2.
3. Rosenfeld SB, Watkinson KK, Thompson BH, MacFarlane DE, Lentz DR. Pulmonary embolism after sequential use of recombinant factor VIIa and activated prothrombin complex concentrate in a factor VIII inhibitor patient. Thromb Haemost. 2002;87:925-6.
4. Horan JT, Francis CW. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation. Semin Thromb Hemost. 2001;27:657-66.
5. Noda A, Wada H, Kusiya F, Sakakura M, Onishi K, Nakatani K, et al. Plasma levels of heparin cofactor II (HCII) and thrombin-HCII complex in patients with disseminated intravascular coagulation. Clin Appl Thromb Hemost. 2002:8:265-71.
6. von Heymann C, Hotz H, Konertz W, Kox WJ, Spies C. Successful treatment of refractory bleeding with recombinant factor VIIa after redo coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2002;16:615-6.
7. Gallistl S, Cvirn G, Muntean W. Recombinant factor VIIa does not induce hypercoagulability in vitro. Thromb Haemost. 1999;81:245-9.
8. Dietrich W, Spannagl M. Caveat against the use of activated recombinant factor VII for intractable bleeding in cardiac surgery. Anesth Analg. 2002;94:1365-7.